Verily Life Sciences receives approval for its new wearable vital signs monitor

Verily Lifesciences wearable Vitals Patch

Verily Lifesciences received the approval for their new Verily Patch product and the associated app.

Verily Patch is the wearable vital signs monitor that is being offered by the company. This approval comes on a day when the company announced a new $700 capital investment.

Related reading

Verily’s new wearable vital signs monitor development.

Verily today announced a $700 million investment round from current investors, including Alphabet, Silver Lake, Temasek, Ontario Teachers’ Pension Plan, and others. The capital will be used to support the rapid expansion of some of Verily’s leading commercial businesses.

The request for approval was filed on Oct 5th, 2020, and was recently approved.

From the various screenshots embedded in the filing, it appears that the patch helps with remote monitoring of vital signs.

According to the filing, the new Verily Patch is not intended for medical diagnosis or patient monitoring purposes. Does it mean that the new wearable patch sensor is something that Verily plans on using for internal studies or more as a wellness monitor? 

Verily Patch

The company already has a wearable product called the Study Watch, which collects biometric health information, such as ECG, heart rate, electrodermal activity, and inertial movements.

Data from the study watch is processed and stored in their cloud platform using proprietary algorithms and translated into program-specific dashboards or insights.

It is unclear from the reg filing how the new wearable vital signs patch will be used.

As an Amazon Associate MyHealthyApple may earn commissions from qualifying purchases using our links

LEAVE A REPLY

Please enter your comment!
Please enter your name here

This site uses Akismet to reduce spam. Learn how your comment data is processed.